Immunoprecise Antibodies shares owned by Gradient Capital Advisors
Quarter-by-quarter ownership of Immunoprecise Antibodies (IPA) shares owned by Gradient Capital Advisors
from 13F filings
Historical chart of Gradient Capital Advisors investment in Immunoprecise Antibodies
Tip: Access up to 7 years of quarterly data
All positions including Immunoprecise Antibodies held by Gradient Capital Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Immunoprecise Antibodies by Gradient Capital Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $41k | 27k | 1.52 |
| 2023-12-31 | $46k | 27k | 1.71 |
| 2023-09-30 | $49k | 27k | 1.83 |
| 2023-06-30 | $79k | 27k | 2.96 |
| 2023-03-31 | $74k | 27k | 2.77 |
| 2022-12-31 | $140k | 27k | 5.21 |
| 2022-09-30 | $107k | 27k | 3.99 |
| 2022-06-30 | $76k | 20k | 3.80 |
| 2022-03-31 | $103k | 20k | 5.15 |
| 2021-12-31 | $107k | 20k | 5.35 |
| 2021-09-30 | $135k | 22k | 6.22 |
| 2021-06-30 | $131k | 22k | 6.03 |
| 2021-03-31 | $213k | 22k | 9.81 |
| 2020-12-31 | $325k | 22k | 14.96 |